MedAdvisor Ltd Reinstated to ASX Quotation
Key points
- Trading suspension lifted after lodgement of annual financial report
- Securities of MedAdvisor Limited (ASX: MDR) to resume trading on 10 October 2025
- Announcement made by ASX Compliance
Full summary
MedAdvisor Limited (ASX: MDR) has been reinstated to official quotation on the Australian Securities Exchange (ASX) following the lodgement of its annual financial report. The suspension of trading in MDR securities has been lifted, and the company's shares will resume trading on the ASX from the commencement of trading on Friday, 10 October 2025. This announcement was made by ASX Compliance, the regulatory arm of the ASX, indicating that the necessary requirements for the company's reinstatement have been met.
Summary generated by a large language model. Please interpret with care.